Vidya Breeveld-Dwarkasing
Principal Consultant At Keen Access Insights And Founder Of Transmineo.
Vidya perceives market access as a strategic, multi-stakeholder discipline that requires more than technical skills, emphasizing rigorous analysis, challenging pathways, and translating complexity into clear insights.
Vidya Breeveld-Dwarkasing is a senior market access and HTA strategist with nearly two decades of hands-on experience in the pharmaceutical industry and consultancy.
Since 2007, Vidya has worked hands-on in pricing and reimbursement, HTA, payer engagement, and market access strategy—contributing to submissions, navigating cross-functional dynamics, and managing real-world launch execution in complex healthcare systems. She held senior roles at Novartis, AbbVie, Sanofi Pasteur MSD and Sanofi, where she developed deep expertise in stakeholder engagement, cross-functional alignment and strategy execution.
Originally trained as a veterinarian (DVM), Vidya holds a PhD in Biomedical Sciences from Utrecht University and a university teaching qualification. Her translational scientific background underpins her structured, evidence-driven approach to market access and value demonstration.
Her professional journey directly shapes the philosophy behind Keen Access Insights. Vidya approaches market access as a strategic, multi-stakeholder discipline that requires more than technical excellence alone. Her work is grounded in rigorous analysis (“keen”), the willingness to challenge established pathways, and the ability to translate complexity into clear, actionable insights.
Her work with Transmineo extends this philosophy into patient-centered real-world evidence generation.
Together, these activities reflect a single conviction: sustainable access is built early, grounded in robust evidence, aligned with system realities, and anchored in what ultimately matters—patient outcomes.
As a consultant, Vidya cuts through complexity and develops proposals that are rigorous, pragmatic, and execution-ready.